Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564233 · ClinicalTrials.gov registry record · NA
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
A NA study of Cancer and Hematopoietic Stem Cell Transplantation, sponsored by Victor Wang.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06564233: Recruiting NA study of Cancer and Hematopoietic Stem Cell Transplantation, sponsored by Victor Wang.
NCT06564233 is a NA study of Cancer and Hematopoietic Stem Cell Transplantation that is actively recruiting participants, run by Victor Wang. The registered enrollment target is 90 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564233, a NA study of Cancer and Hematopoietic Stem Cell Transplantation, is actively recruiting participants, sponsored by Victor Wang.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogeneic hematopoietic stem cell transplantation (HCT), a randomized controlled trial (RCT) will be conducted of the digital versus usual supportive care program for outpatient HCT recipients. Potential improvements in anxiety and quality of life will be evaluated, with the intent of increasing comfortability with outpatient transplant and expanding the population of eligible patients willing to receive their transplants in an outpatient setting.
Primary Outcome
Hospital Anxiety and Depression Scale (HADS) - Anxiety subscale
Conditions Studied
Interventions
- BEHAVIORAL care.coach Avatar™
Study Locations (1)
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2026-11-29 |
| Phase | NA |
What NCT06564233 shows while recruiting
NCT06564233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which care.coach Avatar™ is the first listed.
NCT06564233 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06564233 about?
NCT06564233 is a clinical study titled "Supportive Care Intervention for Outpatient Stem Cell Transplant Patients". The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogenei...
What is the current status of trial NCT06564233?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-10-21. Estimated completion is 2026-11-29.
What conditions does trial NCT06564233 study?
This clinical trial studies the following conditions: Cancer, Hematopoietic Stem Cell Transplantation.
What interventions are being tested in trial NCT06564233?
The interventions under investigation include: care.coach Avatar™ (BEHAVIORAL).
Who is sponsoring clinical trial NCT06564233?
This trial is sponsored by Victor Wang, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564233 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06564233's enrollment target sits among peer trials
90 337th of 615 higher than 277 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI